Joseph A. Picoraro

Dr. Joseph A. Picoraro


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2022 in Gastrointestinal Endoscopy Clinics of North America
Verified
Journal Article
Closed access
SHSarah Householder
Sarah Householder
JPJoseph A. Picoraro
Joseph A. Picoraro

29 July 2024 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
ASAmanda A. Simard
Amanda A. Simard
SKSwetha Kotamraju
Swetha Kotamraju
JDJennifer R. DeFazio
Jennifer R. DeFazio
JPJoseph A. Picoraro
Joseph A. Picoraro

7 October 2020 in Gastrointestinal Disorders
Verified
Journal Article
Open access
PDF file
Sydney SolomonSydney Solomon
Sydney Solomon
EPEunie Park
Eunie Park
JPJoseph A. Picoraro
Joseph A. Picoraro
Treatment for inflammatory bowel disease (IBD) deserves an informed shared decision-making process between patient and doctor. IBD spans a spectrum of phenotypes that impact each patient uniquely. While treatment has primarily consisted of medical or surgical therapy, dietary approaches have become increasingly relevant. A majority of patients with IBD use some form of dietary modification, and it is common for patients to do this without their physicians’ knowledge. Lack of medical supervision can lead to nutritional deficiencies and a worsening disease state. Some patients work with their medical team to pursue a well-defined exclusion diet as a primary therapy, such as the specific carbohydrate diet, exclusive enteral nutrition, or the Crohn’s disease exclusion diet. The motivations to use dietary therapy for IBD remain unclear and the effectiveness has not been definitively established for many approaches. It is necessary for medical providers to be knowledgeable and to foster open communication with their patients in order to ensure the highest likelihood of remission. This review provides an overview of dietary treatment options, the current knowledge about patient motivations for pursuing dietary therapy, and the roles of patient empowerment and patient activation. We outline areas of improvement for the decision-making process.

7 February 2019 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
JAJeremy Adler
Jeremy Adler
AGAcham Gebremariam
Acham Gebremariam
SESally J Eder
Sally J Eder
KFKelley R French
Kelley R French
ASAndrew A Singer
Andrew A Singer
GZGeorge Zacur
George Zacur

1 October 2020 in Journal of Pediatric Surgery Case Reports
Verified
Journal Article
Open access
AZAriela Zenilman
Ariela Zenilman
JDJennifer DeFazio
Jennifer DeFazio
CGCornelia Griggs
Cornelia Griggs
JPJoseph A. Picoraro
Joseph A. Picoraro
EFErica M. Fallon
Erica M. Fallon
WMWilliam Middlesworth
William Middlesworth

1 March 2020 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
JPJoseph A. Picoraro
Joseph A. Picoraro
SASharon R. Akabas
Sharon R. Akabas
NLNeal S. LeLeiko
Neal S. LeLeiko